Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 41 results found. Search for [ Rheumatoid Arthritis ]

Results 1 to 21 of 41
PTI
August 2, 2019



E Kumar Sharma
New Delhi, May 13, 2019
The summer heat can play havoc with your gut and upset the microbiome balance, but the right diet will keep you strong and healthy.


PTI
April 25, 2019



PTI
April 6, 2019



PTI
March 26, 2019



PTI
March 11, 2019



PTI
March 9, 2019



PTI
January 7, 2019



PTI
January 7, 2019



PTI
October 11, 2018



PB Jayakumar
New Delhi, June 28, 2018
Enbrel had global brand sales of approximately $11.6 billion for the 12 months ending December 31, 2017, according to IQVIA.


P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


PB Jayakumar
New Delhi, February 21, 2018
The competition to tap large molecule structured complex bio-similars or off-patent biotech drugs is heating up.


PB Jayakumar
New Delhi, December 10, 2017
Though it is used as jewellery or for investment purposes, gold has many technology applications


BT Online
New Delhi, April 17, 2017
The S&P BSE Sensex was settled at 29,413.66, down 47.79 points while Nifty50 was ended at 9,139.30, 11.50 points lower.


BT Online
New Delhi, April 6, 2017
The S&P BSE Sensex ended the day at 29,927.34, down 46.90 points (0.16%) while the Nifty50 ended the day at 9,261.95, down 3.20 points (0.03%).


by E Kumar Sharma
Delhi, January 21, 2017
Top pharma companies - Driven by inorganic growth opportunities - are also learning to live with more debt.


By E. Kumar Sharma
Delhi, July 23, 2016
Indian drug makers are slugging it out with Big Pharma over launch of biosimilars. Will they be able to hold their fort in this emerging space?


Reuters
Mumbai, September 7, 2015
Pfizer is reviewing its options for further action, a Mumbai-based company spokesman said in an emailed statement.


PTI
New Delhi, December 11, 2014
Lupin had earlier signed a licensing agreement with Pfizer for Celebrex, which has an annual sales of $2.54 billion in US market, it added.


PAGES 1 OF 3  123